Wells Fargo’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Sell
128,538
-143,073
-53% -$1.35M ﹤0.01% 3249
2025
Q1
$1.47M Buy
271,611
+236,819
+681% +$1.28M ﹤0.01% 3035
2024
Q4
$259K Buy
34,792
+15,290
+78% +$114K ﹤0.01% 4158
2024
Q3
$156K Sell
19,502
-55,801
-74% -$446K ﹤0.01% 4353
2024
Q2
$655K Buy
75,303
+4,331
+6% +$37.7K ﹤0.01% 3409
2024
Q1
$1.47M Buy
70,972
+61,943
+686% +$1.28M ﹤0.01% 2897
2023
Q4
$209K Buy
9,029
+739
+9% +$17.1K ﹤0.01% 4059
2023
Q3
$66.2K Sell
8,290
-4,684
-36% -$37.4K ﹤0.01% 4685
2023
Q2
$113K Buy
12,974
+8,173
+170% +$71.1K ﹤0.01% 4695
2023
Q1
$14.1K Buy
+4,801
New +$14.1K ﹤0.01% 5427
2022
Q4
Sell
-236
Closed -$2K 7188
2022
Q3
$2K Sell
236
-273
-54% -$2.31K ﹤0.01% 5815
2022
Q2
$4K Sell
509
-8,160
-94% -$64.1K ﹤0.01% 5784
2022
Q1
$105K Sell
8,669
-7,232
-45% -$87.6K ﹤0.01% 4980
2021
Q4
$195K Sell
15,901
-43,047
-73% -$528K ﹤0.01% 4913
2021
Q3
$615K Buy
58,948
+56,365
+2,182% +$588K ﹤0.01% 4291
2021
Q2
$23K Buy
2,583
+142
+6% +$1.26K ﹤0.01% 5517
2021
Q1
$25K Buy
2,441
+49
+2% +$502 ﹤0.01% 5726
2020
Q4
$15K Sell
2,392
-11,628
-83% -$72.9K ﹤0.01% 5672
2020
Q3
$72K Sell
14,020
-123
-0.9% -$632 ﹤0.01% 5162
2020
Q2
$108K Sell
14,143
-5,640
-29% -$43.1K ﹤0.01% 4982
2020
Q1
$202K Buy
19,783
+1,298
+7% +$13.3K ﹤0.01% 4516
2019
Q4
$287K Buy
18,485
+1,052
+6% +$16.3K ﹤0.01% 4619
2019
Q3
$316K Buy
17,433
+7,738
+80% +$140K ﹤0.01% 4543
2019
Q2
$159K Buy
9,695
+4,593
+90% +$75.3K ﹤0.01% 4893
2019
Q1
$92K Sell
5,102
-135
-3% -$2.43K ﹤0.01% 5075
2018
Q4
$99K Buy
+5,237
New +$99K ﹤0.01% 5044
2017
Q3
Hold
0
5902
2017
Q2
Hold
0
5834
2017
Q1
Hold
0
5864
2016
Q4
Sell
-100
Closed -$3K 5857
2016
Q3
$3K Hold
100
﹤0.01% 5645
2016
Q2
$3K Hold
100
﹤0.01% 5580
2016
Q1
$3K Buy
+100
New +$3K ﹤0.01% 5690